Skip to main content

Table 2 Demographic and Clinical Data for all Participants (N = 41)

From: Long term follow-up of a phase II trial of multimodal therapy given in a “sandwich” method for stage III, IV, and recurrent endometrial cancer

  Number Percent (%)
Age, years, mean (SD) 41 59.0 (11.5)
Race   
 White 35 85.4
 Other 5 12.2
 Missing 1 2.4
Disease Status   
 Primary 39 95.1
 Recurrence 2 4.9
Stage   
 IC (recurrence) 1 2.4
 IIA (recurrence) 1 2.4
 IIIA 10 24.4
 IIIC 21 51.2
 IVA 1 2.4
 IVB 7 17
Grade   
 1 7 17.1
 2 17 41.5
 3 17 41.5
Histology   
 Endometrioid 32 78.1
 Serous 4 9.8
 Mucinous 1 2.4
 Adeno Squamous 3 7.3
 Endometrioid + Serous 1 2.4
Surgery Type   
 Open 32 84.2
 Minimally Invasive 6 15.8
Missing 3  
Extent of lymphadenectomy   
 Any lymphadenectomy 36 92.3
 Pelvic lymphadenectomy 5 13.9
 Para-aortic lymphadenectomy 1 2.8
 Both 30 83.3